Liquid chromatography-tandem mass spectrometry analysis of a ratio-optimized drug pair of Sophora flavescens Aiton and Coptis chinensis Franch and study on the mechanism of anti-colorectal cancer effect of two alkaloids thereof

The drug pair consisting of Sophora flavescens Aiton (Sophorae flavescentis radix, Kushen) and Coptis chinensis Franch. (Coptidis rhizoma, Huanglian), as described in Prescriptions for Universal Relief (Pujifang), is widely used to treat laxation. Matrine and berberine are the major active components of Kushen and Huanglian, respectively. These agents have shown remarkable anti-cancer and anti-inflammatory effects. A mouse model of colorectal cancer was used to determine the most effective combination of Kushen and Huanglian against anti-colorectal cancer. The results showed that the combination of Kushen and Huanglian at a 1:1 ratio exerted the best anti-colorectal cancer effect versus other ratios. Moreover, the anti-colorectal cancer effect and potential mechanism underlying the effects of matrine and berberine were evaluated by the analysis of combination treatment or monotherapy. In addition, the chemical constituents of Kushen and Huanglian were identified and quantified by liquid chromatography-tandem mass spectrometry (LC-MS/MS). A total of 67 chemical components were identified from the Kushen–Huanglian drug pair (water extraction), and the levels of matrine and berberine were 129 and 232 µg/g, respectively. Matrine and berberine reduced the growth of colorectal cancer and relieved the pathological conditions in mice. In addition, the combination of matrine and berberine displayed better anti-colorectal cancer efficacy than monotherapy. Moreover, matrine and berberine reduced the relative abundance of Bacteroidota and Campilobacterota at phylum level and that of Helicobacter, Lachnospiraceae_NK4A136_group, Candidatus_Arthromitus, norank_f_Lachnospiraceae, Rikenella, Odoribacter, Streptococcus, norank_f_Ruminococcaceae, and Anaerotruncus at the genus level. Western blotting results demonstrated that treatment with matrine and berberine decreased the protein expressions of c-MYC and RAS, whereas it increased that of sirtuin 3 (Sirt3). The findings indicated that the combination of matrine and berberine was more effective in inhibiting colorectal cancer than monotherapy. This beneficial effect might depend on the improvement of intestinal microbiota structure and regulation of the RAS/MEK/ERK-c-MYC-Sirt3 signaling axis.

[1]  Baojie Li,et al.  Berberine increases stromal production of Wnt molecules and activates Lgr5+ stem cells to promote epithelial restitution in experimental colitis , 2022, BMC biology.

[2]  Zheng Wang,et al.  Effects of Sophora flavescens aiton and the absorbed bioactive metabolite matrine individually and in combination with 5-fluorouracil on proliferation and apoptosis of gastric cancer cells in nude mice , 2022, Frontiers in Pharmacology.

[3]  K. Ikeo,et al.  Blocking DCIR mitigates colitis and prevents colorectal tumors by enhancing the GM-CSF-STAT5 pathway. , 2022, Cell reports.

[4]  M. Guo,et al.  Correlations between Intestinal Microbiota and Clinical Characteristics in Colorectal Adenoma/Carcinoma , 2022, BioMed research international.

[5]  C. Png,et al.  Alterations in co-abundant bacteriome in colorectal cancer and its persistence after surgery: a pilot study , 2022, Scientific Reports.

[6]  Yong Guo,et al.  Berberine inhibits intestinal carcinogenesis by suppressing intestinal pro-inflammatory genes and oncogenic factors through modulating gut microbiota , 2022, BMC cancer.

[7]  Wei Zhao,et al.  Danggui-Shaoyao-San Attenuates Cognitive Impairment via the Microbiota–Gut–Brain Axis With Regulation of Lipid Metabolism in Scopolamine-Induced Amnesia , 2022, Frontiers in Immunology.

[8]  Yuzhu Cao,et al.  Danshensu Attenuated Epithelial-Mesenchymal Transformation and Chemoresistance of Colon Cancer Cells Induced by Platelets. , 2022, Frontiers in bioscience.

[9]  Meicun Yao,et al.  Network Pharmacology and Transcriptomic Sequencing Analyses Reveal the Molecular Mechanism of Sanguisorba officinalis Against Colorectal Cancer , 2022, Frontiers in Oncology.

[10]  Tingxu Yan,et al.  Wei-Tong-Xin ameliorates functional dyspepsia via inactivating TLR4/MyD88 by regulating gut microbial structure and metabolites. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[11]  Z. Geng,et al.  Berberine regulates short-chain fatty acid metabolism and alleviates the colitis-associated colorectal tumorigenesis through remodeling intestinal flora. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[12]  Chao Huang,et al.  Suppression of Berberine and Probiotics (in vitro and in vivo) on the Growth of Colon Cancer With Modulation of Gut Microbiota and Butyrate Production , 2022, Frontiers in Microbiology.

[13]  Hao Wu,et al.  Effects of Jianpi Lishi Jiedu granules on colorectal adenoma patients after endoscopic treatment: study protocol for a randomized, double-blinded, placebo-controlled clinical trial , 2022, Trials.

[14]  Xi-jun Wang,et al.  Prediction of the mechanism of Dachengqi Decoction treating colorectal cancer based on the analysis method of " into serum components -action target-key pathway". , 2022, Journal of ethnopharmacology.

[15]  Xiulong Ma,et al.  Matrine impedes colorectal cancer proliferation and migration by downregulating endoplasmic reticulum lipid raft associated protein 1 expression , 2022, Bioengineered.

[16]  M. Marzorati,et al.  The Modulation of Chaihu Shugan Formula on Microbiota Composition in the Simulator of the Human Intestinal Microbial Ecosystem Technology Platform and its Influence on Gut Barrier and Intestinal Immunity in Caco-2/THP1-Blue™ Cell Co-Culture Model , 2022, Frontiers in Pharmacology.

[17]  Q. Ji,et al.  Jianpi Jiedu Recipe inhibits colorectal cancer liver metastasis via regulating ITGBL1-rich extracellular vesicles mediated activation of cancer-associated fibroblasts. , 2022, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[18]  W. Garrett,et al.  Colorectal cancer: the facts in the case of the microbiota , 2022, The Journal of clinical investigation.

[19]  L. Zeng,et al.  β-catenin correlates with the progression of colon cancers and berberine inhibits the proliferation of colon cancer cells by regulating the β-catenin signaling pathway. , 2022, Gene.

[20]  Juan Feng,et al.  Biological Response Profiling Reveals the Functional Differences of Main Alkaloids in Rhizoma Coptidis , 2021, Molecules.

[21]  Mingyu Sun,et al.  A correlational study of Weifuchun and its clinical effect on intestinal flora in precancerous lesions of gastric cancer , 2021, Chinese Medicine.

[22]  S. Gibbons,et al.  Genomic and functional characterization of a mucosal symbiont involved in early-stage colorectal cancer. , 2021, Cell host & microbe.

[23]  Yan-lai Sun,et al.  Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome-associated metabolites in the detection of colorectal cancer and adenoma , 2021, Gut.

[24]  Bian-hua Zhou,et al.  Anticoccidial effect of toltrazuril and Radix Sophorae Flavescentis combination: Reduced inflammation and promoted mucosal immunity. , 2021, Veterinary parasitology.

[25]  Jingwen Liu,et al.  Xiao-Chai-Hu-Tang ameliorates tumor growth in cancer comorbid depressive symptoms via modulating gut microbiota-mediated TLR4/MyD88/NF-κB signaling pathway. , 2021, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[26]  C. Son,et al.  ROS-Mediated Anti-Tumor Effect of Coptidis Rhizoma against Human Hepatocellular Carcinoma Hep3B Cells and Xenografts , 2021, International journal of molecular sciences.

[27]  F. Greten,et al.  The inflammatory pathogenesis of colorectal cancer , 2021, Nature Reviews Immunology.

[28]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[29]  Ziren Su,et al.  Coptisine ameliorates DSS-induced ulcerative colitis via improving intestinal barrier dysfunction and suppressing inflammatory response. , 2021, European journal of pharmacology.

[30]  Wentao Kuai,et al.  Gegen Qinlian decoction enhances immunity and protects intestinal barrier function in colorectal cancer patients via gut microbiota , 2020, World journal of gastroenterology.

[31]  T. Hwang,et al.  Neutrophil elastase inhibitor (MPH-966) improves intestinal mucosal damage and gut microbiota in a mouse model of 5-fluorouracil-induced intestinal mucositis. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[32]  Lanjuan Li,et al.  The Intestinal Microbiota and Colorectal Cancer , 2020, Frontiers in Immunology.

[33]  J. Ji,et al.  Sophoridine suppresses lenvatinib‐resistant hepatocellular carcinoma growth by inhibiting RAS/MEK/ERK axis via decreasing VEGFR2 expression , 2020, Journal of cellular and molecular medicine.

[34]  X. Tong,et al.  Therapeutic mechanisms of traditional Chinese medicine to improve metabolic diseases via the gut microbiota. , 2020, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[35]  M. Alipour.  Molecular Mechanism of Helicobacter pylori-Induced Gastric Cancer , 2020, Journal of Gastrointestinal Cancer.

[36]  Yun Cheng,et al.  Matrine Inhibits Proliferation, Invasion, and Migration and Induces Apoptosis of Colorectal Cancer Cells Via miR-10b/PTEN Pathway. , 2020, Cancer biotherapy & radiopharmaceuticals.

[37]  Xudong Xu,et al.  Berberine inhibits intestinal epithelial barrier dysfunction in colon caused by peritoneal dialysis fluid by improving cell migration. , 2020, Journal of ethnopharmacology.

[38]  Q. Ji,et al.  YYFZBJS ameliorates colorectal cancer progression in ApcMin/+ mice by remodeling gut microbiota and inhibiting regulatory T-cell generation , 2020, Cell Communication and Signaling.

[39]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[40]  Wei Zhang,et al.  Panax notoginseng saponins prevent colitis-associated colorectal cancer development: the role of gut microbiota. , 2020, Chinese journal of natural medicines.

[41]  Qing Yang,et al.  Colorectal cancer occurrence and treatment based on changes in intestinal flora. , 2020, Seminars in cancer biology.

[42]  Jun Yu,et al.  High-Fat Diet Promotes Colorectal Tumorigenesis through Modulating Gut Microbiota and Metabolites. , 2020, Gastroenterology.

[43]  K. Qu,et al.  Myc-mediated SDHA acetylation triggers epigenetic regulation of gene expression and tumorigenesis , 2020, Nature Metabolism.

[44]  Li-Qin Zeng,et al.  Synergistic protection of astragalus polysaccharides and matrine against ulcerative colitis and associated lung injury in rats , 2020, World journal of gastroenterology.

[45]  Hao Xu,et al.  The administration of Escherichia coli Nissle 1917 ameliorates irinotecan-induced intestinal barrier dysfunction and gut microbial dysbiosis in mice. , 2019, Life sciences.

[46]  H. Yamawaki,et al.  Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer , 2019, International journal of molecular sciences.

[47]  S. Luo,et al.  Rhubarb Peony Decoction ameliorates ulcerative colitis in mice by regulating gut microbiota to restoring Th17/Treg balance. , 2019, Journal of ethnopharmacology.

[48]  Xuan-min Chen,et al.  Matrine Mediates Inflammatory Response via Gut Microbiota in TNBS-Induced Murine Colitis , 2019, Front. Physiol..

[49]  C. Jobin,et al.  Campylobacter jejuni promotes colorectal tumorigenesis through the action of cytolethal distending toxin , 2018, Gut.

[50]  Ti-Cheng Chang,et al.  SYK‐CARD9 Signaling Axis Promotes Gut Fungi‐Mediated Inflammasome Activation to Restrict Colitis and Colon Cancer , 2018, Immunity.

[51]  Yuling Chen,et al.  SIRT3 Overexpression Inhibits Growth of Kidney Tumor Cells and Enhances Mitochondrial Biogenesis. , 2018, Journal of proteome research.

[52]  J. Li,et al.  Salt-assisted dispersive liquid-liquid microextraction for enhancing the concentration of matrine alkaloids in traditional Chinese medicine and its preparations. , 2018, Journal of separation science.

[53]  H. Tilg,et al.  The Intestinal Microbiota in Colorectal Cancer. , 2018, Cancer cell.

[54]  Xingchun Wang,et al.  Berberine could inhibit thyroid carcinoma cells by inducing mitochondrial apoptosis, G0/G1 cell cycle arrest and suppressing migration via PI3K-AKT and MAPK signaling pathways. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[55]  Frank McCormick,et al.  RAS Proteins and Their Regulators in Human Disease , 2017, Cell.

[56]  N. Barnich,et al.  Microbiota, Inflammation and Colorectal Cancer , 2017, International journal of molecular sciences.

[57]  A. Lin,et al.  FOXAI: a phase II trial evaluating the efficacy and safety of hepatic arterial infusion of oxaliplatin plus fluorouracil/leucovorin for advanced hepatocellular carcinoma , 2017, Gut.

[58]  Yubo Xiao,et al.  Coptisine from Rhizoma Coptidis Suppresses HCT-116 Cells-related Tumor Growth in vitro and in vivo , 2017, Scientific Reports.

[59]  Elena Cerrada,et al.  Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer , 2017, International journal of molecular sciences.

[60]  Kehe Huang,et al.  Matrine ameliorates spontaneously developed colitis in interleukin-10-deficient mice. , 2016, International immunopharmacology.

[61]  F. Ryan,et al.  Tumour-associated and non-tumour-associated microbiota in colorectal cancer , 2016, Gut.

[62]  H. Brody.  Colorectal cancer , 2015, Nature.

[63]  Xi-jing Wang,et al.  Matrine reduces the proliferation and invasion of colorectal cancer cells via reducing the activity of p38 signaling pathway. , 2014, Acta biochimica et biophysica Sinica.

[64]  J. Petrosino,et al.  The Gut Microbiome Modulates Colon Tumorigenesis , 2013, mBio.

[65]  Chi V Dang,et al.  MYC on the Path to Cancer , 2012, Cell.

[66]  Scott M Lippman,et al.  Targeting the MAPK–RAS–RAF signaling pathway in cancer therapy , 2012, Expert opinion on therapeutic targets.

[67]  Yuefan Zhang,et al.  Sophocarpine and matrine inhibit the production of TNF-alpha and IL-6 in murine macrophages and prevent cachexia-related symptoms induced by colon26 adenocarcinoma in mice. , 2008, International immunopharmacology.

[68]  C. Baird.  The pilot study. , 2000, Orthopedic nursing.

[69]  Professor Wei Cui.  Integrated analysis of the faecal metagenome and serum metabolome reveals the role of gut microbiome- associated metabolites in the detection of colorectal cancer and adenoma , 2022 .

[70]  L. Ferguson,et al.  Role of gut microbiota in , 2009 .